Articles from Glooko, Inc.

Glooko, Inc., a global digital health company focused on helping clinicians address the growing challenges of glycemic safety and diabetes management across the care continuum, today announced that Mark Clements, M.D., Ph.D., its Chief Medical and Strategy Officer, has been recognized by Becker's Healthcare as one of its 2026 'Great leaders in healthcare.'

Glooko, Inc., a globally integrated digital healthcare company focused on helping healthcare systems solve the growing challenges of glycemic safety and diabetes management across care settings, today announced data presented at the American Association of Clinical Endocrinology (AACE) Annual Meeting. The evidence, reflecting outcomes from a three-year retrospective analysis spanning from January 2023 through December 2025, demonstrated that EndoTool IV achieved a 98% reduction in severe hypoglycemia across a large, 19-hospital health system as compared with historical paper protocols. The poster titled, 'Virtual Elimination of Severe Hypoglycemia Utilizing a Computerized Insulin Dosing Algorithm for Intravenous Insulin Infusions,' was authored and presented by Joseph Aloi, M.D., F.A.C.E., Section Chief, Endocrinology and Metabolism at Advocate Health Wake Forest Baptist Hospital and Paul Chidester, M.D., Medical Director, EndoTool, at Glooko.

Glooko, Inc., a globally integrated digital healthcare company focused on helping healthcare systems solve the growing challenges of glycemic safety and diabetes management across care settings, today announced that the Glooko platform will integrate with the Roche Accu-Chek SmartGuide continuous glucose monitoring (CGM) solution across select European countries, subject to local availability.*

Glooko, Inc. a global leader in connected care and glycemic management solutions, today announced the appointment of Mark Laret, one of the nation’s leading healthcare operators and strategists, to its Board of Directors.

Glooko, Inc., a leading provider of remote patient monitoring and digital health solutions for diabetes, today announced that it has acquired Monarch Medical Technologies, the developer of the EndoTool® Glucose Management System. EndoTool is an industry-leading software platform for inpatient insulin dosing and glycemic management. This strategic acquisition expands Glooko’s connected care capabilities into inpatient glycemic management, complementing its strong foundation in outpatient diabetes management and shaping the future of a single, integrated solution that will support patients and clinicians across the full continuum of care.

Glooko, Inc., a global integrated digital health company connecting patients, providers, biopharma, and medical device partners, announced today that its Glooko Patient Portal for Professionals is now available in the Epic Showroom, enabling healthcare providers to integrate Glooko’s solutions seamlessly with Epic’s electronic health record (EHR) system. This integration allows clinicians to access timely patient data directly within Epic, eliminating the need for additional logins or manual data transfers, ultimately enhancing workflow efficiency and patient care.

Glooko, Inc., a global integrated digital health company connecting patients, providers, biopharma and medical device partners, today announced that it has secured a $100 million Series F financing. The Company’s Board of Directors also announced the appointment of Mike Alvarez as Chief Executive Officer.